LTI-03 is formulated as a dry powder inhalation therapy that's designed to help ease fibrosis and symptoms of idiopathic ...

GRI Bio reached an interim enrollment goal for a clinical trial testing GRI-0621, a therapy targeting natural killer T-cells ...

Pulmonary fibrosis (PF) is a respiratory condition that causes the formation of scar tissue in the lungs. It is progressive disease and can take years to progress. Because of thickening lung tissue, ...

An EU committee is recommending that tranilast, the active ingredient in a pulmonary fibrosis drug candidate, be awarded ...

A cancer immunotherapy known as ipilimumab was able to reduce scar formation and promote tissue regeneration in the lungs of a mouse model of idiopathic pulmonary fibrosis (IPF). Treatment boosted the ...

My adventure continues. At this point, regular readers might be thinking, “What now?” Some may even pause to make some popcorn before reading further. I was surprised when I was diagnosed with ...

Disrupting the rhythm of day-to-day life with pulmonary fibrosis comes at a cost. My pretransplant medications can be best described as a primer for what was to come. Following my bilateral lung ...

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.